{
    "id": 4838,
    "name": "myoepithelial carcinoma",
    "source": "DOID",
    "definition": "A carcinoma that derives_from myoepithelial cells. [url:http\\://www.diagnosticpathology.org/content/3/1/7]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:4838",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT02601937",
            "title": "A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma",
            "phase": "Phase I",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 2683,
                    "therapyName": "Tazemetostat",
                    "synonyms": null
                }
            ]
        }
    ]
}